Scleroderma is an autoimmune, rheumatic, and chronic disease that affects the body by hardening connective tissue, according to the Johns Hopkins Scleroderma Center. For the almost 500,000 people in ...

Early intervention in patients with SSc can help modify disease progression prior to the occurrence of irreversible organ damage.

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

SAN FRANCISCO--(BUSINESS WIRE)--The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that Sanofi will contribute the first ...

CHICAGO (WLS) -- Organizers with the Scleroderma Foundation of Greater Chicago will host the 14th annual 'Cooking Up A Cure' fundraising event on Thursday. Scleroderma is an autoimmune disease that ...

Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology. Characterized by ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Pulmonary arterial hypertension’s prevalence and rate of progression in patients with connective ...

Following the 2017 American College of Rheumatology (ACR) Annual Meeting—held in San Diego, California, November 3-8—Medscape spoke with Hospital for Special Surgery rheumatologists Dr Robert F.

Are autoimmune diseases fatal? Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system ...